• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中的铁死亡:机制、进展与治疗前景

Ferroptosis in the tumor microenvironment: mechanisms, advances, and therapeutic perspectives.

作者信息

Gao Weijuan, Tan Jiani, Yu Chengtao

机构信息

The First Clinical School of Nanjing University of Chinese Medicine, Nanjing, China.

出版信息

Front Oncol. 2025 Aug 22;15:1650219. doi: 10.3389/fonc.2025.1650219. eCollection 2025.

DOI:10.3389/fonc.2025.1650219
PMID:40919170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12411422/
Abstract

Ferroptosis is a regulated, non-apoptotic form of cell death marked by the accumulation of iron-dependent lipid peroxides. This process causes rapid rupture of the plasma membrane and the release of intracellular contents. Ferroptosis acts as an intrinsic tumor-suppressive mechanism. It plays a crucial role in tumor progression, metastasis, and resistance to standard therapies, including chemotherapy and radiotherapy. Its unique molecular mechanisms confer significant therapeutic potential. In recent years, multiple experimental therapies aiming to induce ferroptosis have been developed for cancer treatment. Although these therapies show promise in controlling tumor growth, their effects on the tumor microenvironment (TME) require further investigation. Recent studies indicate that distinct cell populations within the TME have different sensitivities to ferroptosis. This variability may lead to unintended effects, such as damage to normal cells or increased inflammation, resulting in toxicity. Cells in the TME can either undergo ferroptosis or modulate its regulation through intercellular signaling and interactions. Notably, ferroptosis-related interactions between tumor cells and other components of the TME, such as immune cells, stromal cells, and endothelial cells, are central to TME remodeling. This mini-review summarizes recent advances in ferroptosis mechanisms and highlights the dynamic interplay between ferroptosis and the TME. It also discusses the prospects and challenges of ferroptosis-based cancer therapies.

摘要

铁死亡是一种受调控的非凋亡性细胞死亡形式,其特征是铁依赖性脂质过氧化物的积累。这个过程会导致质膜迅速破裂并释放细胞内物质。铁死亡作为一种内在的肿瘤抑制机制,在肿瘤进展、转移以及对包括化疗和放疗在内的标准疗法的抗性中发挥着关键作用。其独特的分子机制具有显著的治疗潜力。近年来,已开发出多种旨在诱导铁死亡的实验性疗法用于癌症治疗。尽管这些疗法在控制肿瘤生长方面显示出前景,但它们对肿瘤微环境(TME)的影响仍需进一步研究。最近的研究表明,TME内不同的细胞群体对铁死亡具有不同的敏感性。这种变异性可能会导致意外的影响,如对正常细胞的损伤或炎症增加,从而产生产生毒性。TME中的细胞可以经历铁死亡,也可以通过细胞间信号传导和相互作用来调节其调控。值得注意的是,肿瘤细胞与TME的其他成分(如免疫细胞、基质细胞和内皮细胞)之间与铁死亡相关的相互作用是TME重塑的核心。本综述总结了铁死亡机制的最新进展,强调了铁死亡与TME之间的动态相互作用。它还讨论了基于铁死亡的癌症疗法的前景和挑战。

相似文献

1
Ferroptosis in the tumor microenvironment: mechanisms, advances, and therapeutic perspectives.肿瘤微环境中的铁死亡:机制、进展与治疗前景
Front Oncol. 2025 Aug 22;15:1650219. doi: 10.3389/fonc.2025.1650219. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Targeting Ferroptosis With Natural Products to Treat Diabetes and Its Complications: Opportunities and Challenges.利用天然产物靶向铁死亡治疗糖尿病及其并发症:机遇与挑战
Phytother Res. 2025 Jul 9. doi: 10.1002/ptr.70028.
4
M1 Macrophage-Derived TNF-α Promotes Pancreatic Cancer Ferroptosis Via p38 MAPK-ACSL4 Pathway.M1型巨噬细胞衍生的肿瘤坏死因子-α通过p38丝裂原活化蛋白激酶-长链脂酰辅酶A合成酶4途径促进胰腺癌铁死亡。
Curr Mol Med. 2025 Jul 10. doi: 10.2174/0115665240374551250630075409.
5
Short-Term Memory Impairment短期记忆障碍
6
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.肿瘤突变负荷与肿瘤微环境之间的相互作用可预测泛癌抗PD-1/PD-L1治疗的预后。
Front Immunol. 2025 Jul 24;16:1557461. doi: 10.3389/fimmu.2025.1557461. eCollection 2025.
7
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
8
Interplay of oxidative stress and antioxidant mechanisms in cancer development and progression.氧化应激与抗氧化机制在癌症发生和发展中的相互作用。
Arch Toxicol. 2025 Sep 4. doi: 10.1007/s00204-025-04146-5.
9
Ferroptosis and Nrf2 Signaling in Head and Neck Cancer: Resistance Mechanisms and Therapeutic Prospects.头颈癌中的铁死亡与Nrf2信号传导:耐药机制与治疗前景
Antioxidants (Basel). 2025 Aug 13;14(8):993. doi: 10.3390/antiox14080993.
10
An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.三阴性乳腺癌中与化疗耐药相关的癌症干细胞存活途径的最新进展。
Future Oncol. 2025 Mar;21(6):715-735. doi: 10.1080/14796694.2025.2461443. Epub 2025 Feb 12.

本文引用的文献

1
Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis.糖胺聚糖驱动的脂蛋白摄取可保护肿瘤免受铁死亡。
Nature. 2025 Jun 11. doi: 10.1038/s41586-025-09162-0.
2
Lactate dehydrogenase B facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8 T cells.乳酸脱氢酶B促进肿瘤浸润性CD8 T细胞的二硫键化程序性坏死和耗竭。
Nat Cell Biol. 2025 Jun 3. doi: 10.1038/s41556-025-01673-2.
3
GPX4-AUTAC induces ferroptosis in breast cancer by promoting the selective autophagic degradation of GPX4 mediated by TRAF6-p62.
GPX4-AUTAC通过促进由TRAF6-p62介导的GPX4选择性自噬降解来诱导乳腺癌中的铁死亡。
Cell Death Differ. 2025 May 20. doi: 10.1038/s41418-025-01528-1.
4
Lipid peroxidation, ferroptosis, and antioxidants.脂质过氧化、铁死亡与抗氧化剂。
Free Radic Biol Med. 2025 Sep;237:228-238. doi: 10.1016/j.freeradbiomed.2025.05.393. Epub 2025 May 13.
5
Sickle cell disease induces chromatin introversion and ferroptosis in CD8 T cells to suppress anti-tumor immunity.镰状细胞病诱导CD8 T细胞中的染色质内陷和铁死亡以抑制抗肿瘤免疫。
Immunity. 2025 Jun 10;58(6):1484-1501.e11. doi: 10.1016/j.immuni.2025.04.020. Epub 2025 May 12.
6
Tumor cell-intrinsic BIN1 deficiency promotes the immunosuppression and impedes ferroptosis of non-small cell lung cancer via G3BP1-mediated degradation of STAT1.肿瘤细胞内在的BIN1缺陷通过G3BP1介导的STAT1降解促进非小细胞肺癌的免疫抑制并阻碍铁死亡。
J Exp Clin Cancer Res. 2025 May 9;44(1):141. doi: 10.1186/s13046-025-03404-9.
7
Activation of lysosomal iron triggers ferroptosis in cancer.溶酶体铁的激活引发癌症中的铁死亡。
Nature. 2025 May 7. doi: 10.1038/s41586-025-08974-4.
8
Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response.索诺托克拉克斯(BGB-11417)可协同增强放射治疗引发的抗肿瘤免疫反应。
Cancer Lett. 2025 Aug 10;625:217759. doi: 10.1016/j.canlet.2025.217759. Epub 2025 Apr 29.
9
PSAT1 impairs ferroptosis and reduces immunotherapy efficacy via GPX4 hydroxylation.PSAT1通过GPX4羟基化损害铁死亡并降低免疫治疗效果。
Nat Chem Biol. 2025 Apr 25. doi: 10.1038/s41589-025-01887-3.
10
Exosomal SLC1A5 from senescent endothelial cells promotes gastric cancer progression by dampening ferroptosis via the EGFR/SRC/YAP1/GPX4 signaling.衰老内皮细胞来源的外泌体SLC1A5通过EGFR/SRC/YAP1/GPX4信号通路抑制铁死亡,从而促进胃癌进展。
Free Radic Biol Med. 2025 Aug 1;235:25-42. doi: 10.1016/j.freeradbiomed.2025.04.029. Epub 2025 Apr 19.